Chemed (CHE) Long-Term Investments (2009 - 2026)

Chemed (CHE) has reported Long-Term Investments for 18 consecutive years, with $143.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Long-Term Investments rose 12.37% year-over-year to $143.8 million; the TTM figure through Mar 2026 stood at $143.8 million (up 12.37% YoY), while the FY2025 annual figure was $140.3 million, up 7.17% from the prior year.
• Long-Term Investments came in at $143.8 million for Q1 2026 at Chemed, up from $140.3 million in the prior quarter.
• The five-year high for Long-Term Investments was $143.8 million in Q1 2026, with the low at $90.1 million in Q3 2022.
• Average Long-Term Investments over 5 years is $115.3 million, with a median of $117.6 million recorded in 2024.
• Across the five-year window, Long-Term Investments retreated 11.71% in 2022 and climbed 23.4% in 2024, its largest moves.
• Year by year, Long-Term Investments stood at $93.2 million in 2022, then grew by 13.87% to $106.1 million in 2023, then increased by 23.4% to $131.0 million in 2024, then climbed by 7.17% to $140.3 million in 2025, then advanced by 2.44% to $143.8 million in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $143.8 million, $140.3 million, and $136.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.